Cn /En

News Center

——

Company news

Industry news

Introduction to the iHuPDX model of InnoModels Biotechnology

Author:

InnoModels

Release time:

2024-08-16

The iHuPDX model of InnoModels Biotechnology is a xenotransplantation technology based on individual patient's tumor cells, aiming to establish a more realistic and individualized cancer model.
The iHuPDX technology provides a tumor model that more closely matches the patient's actual condition by collecting cancer tissue samples from the patient and transplanting them into an animal, such as a mouse, to form an individualized transplanted tumor. Key advantages of this technology include.
Individualized Disease Models: iHuPDX technology establishes highly individualized disease models based on individual patient's tumor cells, which helps to provide a more comprehensive understanding of the patient's tumor characteristics, and providing important support for precision medicine.

Drug response prediction: Due to the highly individualized nature of the model, iHuPDX technology can be used to test the response of different drugs to a specific patient's tumor, providing a powerful tool for the development of personalized treatment plans, which is expected to improve the success rate of treatment. for the development of personalized treatment plans, which is expected to improve the success rate of treatment.
New perspectives in cancer research: iHuPDX technology enables researchers to probe more deeply into the differences in tumor heterogeneity among different patients, helping to reveal the diversity of cancers and providing important information for the development of individualized treatment strategies. strategy development.
Founded by scientists from Novo Nordisk China R&D Center, SinoMediGuanco, and the Institute of Immunology at Shanghai Jiao Tong University, InnoModels Biotechnology (Beijing) Co., Ltd. is confident in the future of iHuPDX technology. With the deepening of biomedical research and continuous technological innovation, iHuPDX is expected to play a more important role in the field of personalized medicine. In the future, we can expect to see more research results and application scenarios related to iHuPDX technology.

Immuno-co-culture killing model platform by InnoModels Biotechnology

Applications of InnoModels Biotechnology's CDX modeling

Immuno-co-culture killing model platform by InnoModels Biotechnology

Applications of InnoModels Biotechnology's CDX modeling

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License